Philipp L. C.
- Country
- Germany
- Department
- 2502: Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie
Research Overview
- Long-term Safety of Asciminib in Patients With Philadelphia Chromosome-Positive CML or ALL Continuing From Parent Studies
- Phase IIIb Multicenter Open-Label Study of Asciminib Hydrochloride in Chronic Myelogenous Leukemia Patients in Chronic Phase Post-Two or More Tyrosine Kinase Inhibitors
- Phase 1 Evaluation of TERN-701 Safety, Tolerability, Pharmacokinetics, and Efficacy in Chronic Myeloid Leukemia Patients
Data & Insights
Has run more than one trial at 24 of 92 partner sites.
Specializations
Chronic Myeloid Leukemia Research
This investigator specializes in the treatment of chronic myeloid leukemia (CML), with particular emphasis on developing innovative therapeutic approaches using tyrosine kinase inhibitors (TKIs) and novel agents like asciminib.
- First-line CML Treatment Strategies
- Novel BCR-ABL1 Inhibitors
- Treatment-resistant CML Management
The research extends to optimizing treatment outcomes for newly diagnosed and previously treated CML patients.
Myeloproliferative Disorders
The investigator focuses on various myeloproliferative neoplasms, including polycythemia vera and essential thrombocythemia, exploring novel therapeutic agents and treatment approaches.
- Hematocrit Control Strategies
- Novel Therapeutic Compounds
- CALR-mutated Neoplasms
Research includes evaluation of innovative treatments such as rusfertide and bomedemstat for various myeloproliferative conditions.
Advanced Therapeutic Development
The investigator is involved in evaluating molecular response rates and developing targeted therapies for hematologic disorders.
- T-cell Redirecting Antibodies
- Treatment Optimization Studies
- Drug Safety and Efficacy Assessment
Research encompasses the development of personalized treatment approaches for various hematologic malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.